Shmeylan Al Harbi

Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory Syndrome

Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri et al. · New England Journal of Medicine · 2020 · 78 citations

Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study

Khalid Al Sulaiman, Ohoud Aljuhani, Khalid Eljaaly et al. · International Journal of Infectious Diseases · 2021 · 59 citations · Full text

Coronavirus Disease 2019, Acute Care, Clinical Epidemiology +9

Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study

Khalid Al Sulaiman, Ohoud Aljuhani, Khalid Bin Saleh et al. · Scientific Reports · 2021 · 52 citations · Full text

Association between phosphate disturbances and mortality among critically ill patients with sepsis or septic shock

Shmeylan Al Harbi, Hasan M. Al‐Dorzi, Albatool M. Al Meshari et al. · BMC Pharmacology and Toxicology · 2021 · 44 citations · Full text

Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study

Khalid Al Sulaiman, Ghazwa B. Korayem, Ali F. Altebainawi et al. · Critical Care · 2022 · 42 citations · Full text